Pacer Advisors’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-327
Closed -$14.9K 2604
2024
Q2
$14.9K Sell
327
-233
-42% -$10.6K ﹤0.01% 3462
2024
Q1
$37.1K Buy
+560
New +$37.1K ﹤0.01% 3293
2021
Q2
Sell
-790
Closed -$49K 1484
2021
Q1
$49K Buy
790
+358
+83% +$22.2K ﹤0.01% 1439
2020
Q4
$30K Buy
+432
New +$30K ﹤0.01% 1462